Amphastar Pharmaceuticals (AMPH) EBIT Margin (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly EBIT Margin of 7.96% for Q1 2026, down 1391.0% year-over-year from 0.62% in Q1 2025, and down 59.05% quarter-over-quarter from 19.45% in Q4 2025.
Amphastar Pharmaceuticals (AMPH) EBIT Margin (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' EBIT Margin history runs 14 years deep, the most recent figure standing at 7.96% for Q1 2026.
- In Q1 2026, EBIT Margin fell 1391.0% year-over-year to 7.96%; the TTM figure through Mar 2026 stood at 16.2% (down 1045.0% YoY), while the FY2025 annual figure was 19.5%, down 856.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 7.96%, down from 19.45% in the prior quarter.
- The five-year high for EBIT Margin was 40.25% in Q3 2023, with the low at 7.96% in Q1 2026.
- The 5-year median for EBIT Margin is 24.19% (2025), against an average of 23.77%.
- The sharpest annual moves came in 2023 and 2025: EBIT Margin soared 2092 bps in 2023, then tumbled 1664 bps in 2025.
- Amphastar Pharmaceuticals' EBIT Margin stood at 28.02% in 2022, then grew by 8 bps to 30.31% in 2023, then declined by 20 bps to 24.2% in 2024, then retreated by 20 bps to 19.45% in 2025, then slumped by 59 bps to 7.96% in 2026.
- Business Quant data shows AMPH's EBIT Margin at 7.96% in Q1 2026, 19.45% in Q4 2025, and 13.2% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 933.76 Mn | 643.64 Mn | 93.47 Mn | 21.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.60% |
| Mar 31, 2026 | 7.96% |
| Dec 31, 2025 | 19.45% |
| Sep 30, 2025 | 13.20% |
| Jun 30, 2025 | 24.19% |
| Mar 31, 2025 | 21.87% |
| Dec 31, 2024 | 24.20% |
| Sep 30, 2024 | 29.83% |
| Jun 30, 2024 | 30.27% |
| Mar 31, 2024 | 27.94% |
| Dec 31, 2023 | 30.31% |
| Sep 30, 2023 | 40.25% |
| Jun 30, 2023 | 25.32% |
| Mar 31, 2023 | 23.88% |
| Dec 31, 2022 | 28.02% |
| Sep 30, 2022 | 19.34% |
| Jun 30, 2022 | 20.10% |
| Mar 31, 2022 | 17.96% |
| Dec 31, 2021 | 20.06% |
| Sep 30, 2021 | 22.08% |